Browse By: Country ι Category ι Tag

Rheumatoid Arthritis Pharmacotherapeutics Market - Global Industry Size, Market Share, Trends, Analysis And Forecast, 2012 - 2018

View Report Details
Description

Treatment options for rheumatoid arthritis (RA) are expanding as a result of increasing research activities and more explicit understanding of the pathophysiology of diseases. For the treatment of RA, novel selective inhibitors such as cyclooxygenase-2 (COX-2) are used along with the non-steroidal anti-inflammatory drugs. Although COX-2 is used in treatment of RA, it has several side effects associated with the upper gastrointestinal region.  Currently, use of disease modifying antirheumatic drugs is recommended by most professionals in the early stages of disease.  The rheumatoid arthritis pharmacotherapeutics market is categorized as follows: Tumor Necrosis Factor (T... Click here for more details


Musculoskeletal Disorders Therapeutics to 2016 - Introduction of Monoclonal Antibodies with First - in - class Mechanism of Action to Increase Treatment Options in Osteoporosis and Rheumatoid Arthritis
GBI Research’s report, “Musculoskeletal Therapeutics to 2016 - Introduction of Monoclonal Antibodies with First-in-class Mechanism of Action to Increase Treatment Options in Osteoporosis and Rheumatoid Arthritis, provides in-depth analysis of unmet needs, drivers and barriers t
Published Date: Oct 2010
Price: $3500
Arthritis Therapeutics Market to 2016 - Biologics Revolutionize Treatment of Rheumatoid Arthritis and Psoriatic Arthritis
GBI Research’s new report, “Arthritis Therapeutics Market to 2016 - Biologics Revolutionize Treatment of Rheumatoid Arthritis (RA) and Psoriatic Arthritis (PsA)”, provides in-depth analysis of unmet needs, drivers and barriers that impact the global hepatitis therapeutics
Published Date: Oct 2010
Price: $3500
Anti-Inflammatory Therapeutics Market to 2017 - Respiratory Diseases and Arthritis Continue to Dominate
GBI Research, the leading business intelligence provider, has released its latest research, Anti-Inflammatory Therapeutics Market to 2017 - Respiratory Diseases and Arthritis Continue to Dominate, which provides insights into anti-inflammatory therapeutics revenue forecasts until 2017. The repor
Published Date: Oct 2011
Price: $3500
Rheumatoid Arthritis - Pipeline Assessment and Market Forecasts to 2017
GlobalData, the industry analysis specialist, has released a new report, Rheumatoid Arthritis - Pipeline Assessment and Market Forecasts to 2017. The report is an essential source of information and analysis on the global rheumatoid arthritis (RA) market. The report identifies the key trends shaping
Published Date: Nov 2010
Price: $2000
Juvenile Rheumatoid Arthritis (JRA) Therapeutics - Pipeline Assessment and Market Forecasts to 2017
GlobalData, the industry analysis specialist, has released its new report, Juvenile Rheumatoid Arthritis (JRA) Therapeutics Pipeline Assessment and Market Forecasts to 2017. The report is an essential source of information and analysis on the global JRA therapeutics market. The report identifies the
Published Date: Jul 2011
Price: $2000
Rheumatoid Arthritis Therapeutics - Pipeline Assessment and Market Forecasts to 2018
GlobalData, the industry analysis specialist, has released its new report, Rheumatoid Arthritis Therapeutics Pipeline Assessment and Market Forecasts to 2018. The report is an essential source of information and analysis on the global rheumatoid arthritis therapeutics market. The report identifies t
Published Date: Sep 2011
Price: $3500
Musculoskeletal Disorders Therapeutics Market to 2017 - Osteoarthritis Market to Decline with Patent Expiry of Celebrex in 2014
GBI Research, the leading business intelligence provider, has released its latest report, “Musculoskeletal Disorders Therapeutics Market to 2017 - Osteoarthritis Market to Decline with Patent Expiry of Celebrex in 2014”. The report is built using data and information sourced from p
Published Date: Jan 2012
Price: $3500
Arthritis Therapeutics Market to 2018 - Novel Oral JAK Inhibitors and Biologic Disease Modifying Anti-Rheumatic Drugs (DMARD) Will Drive Continued Growth Across Key Indications
Arthritis Therapeutics Market to 2018 Novel Oral JAK Inhibitors and Biologic Disease Modifying Anti-Rheumatic Drugs (DMARD) Will Drive Continued Growth Across Key Indications Summary GBI Research’s new report, Arthritis Therapeutics Market to 2018 Novel Oral JAK Inhibitors and Biolog
Published Date: May 2012
Price: $3500
The Rheumatoid Arthritis Community is Swelling with Anticipation as its Research Pipeline Begins to Burst
GlobalData's analysis alert "The Rheumatoid Arthritis Community is Swelling with Anticipation as its Research Pipeline Begins to Burst, analyzes the current pipeline for rheumatoid arthritis drug therapeutics. In addition to the anticipated upcoming approval of Pfizers tofacitinib, the pipeline
Published Date: Jun 2012
Price: $995
Osteoarthritis (OA) Pain Therapeutics - Pipeline Assessment and Market Forecasts to 2019
GlobalData, the industry analysis specialist, has released its new report, Osteoarthritis (OA) Pain Therapeutics - Pipeline Assessment and Market Forecasts to 2019. The report is an essential source of information and analysis on the global Osteoarthritis Pain Therapeutics market. The report identif
Published Date: Jun 2012
Price: $3995

 


 

Related News

Pernod Ricard Targets Premium over Prestige in China Market as ‘New normal’
In China, the international spirits category has begun a ‘new normal’, as stated by Pernod Ricard, with low priced offerings expected to drive growth in future. Since the anti-extravagance legislation came into effect in the country in q2012, international spirits companies such as Pernod witnessed plunging sales.  Subsequently, the drop in demand for high end spirits affected Pernod with 23% drop in sales in China in the financial year 2014. However, last week, the gro
Date: Sep 03

Alcohol Tax Revenue Outweighs Cost to Public Pocket in England
In England, the cost of alcohol use has been over stated by public health campaigners. On the contrary, the revenue from alcohol can touch as much as 6.5 billion GBP, as stated by Institute of Economic Affairs. According to the report, the cost of alcohol to government services such as police, health, welfare, and criminal justice comes out to be 3.9 billion GBP each year, On the other hand, the revenue from alcohol totals to be 10.4billion GBP. The people involved in public health campaig
Date: Sep 03

Healthcare Remote Monitoring Improves Obesity, Diabetes Care: Mayo Clinic
With the medical industry being characterized by reformative practices, using a wide range of the latest technologies, and revising its reimbursement policies in order to boost health outcomes and enhance patient care, the health care remote monitoring market is likely to have a huge influence on the growth as well as strength of the overall industry. New tools and devices such as mobile health technologies and biosensors could potentially strengthen and change the health care remote monitori
Date: Sep 03

Expanded Anti-Discrimination Law for US Healthcare Industry
The United States government proposed on Thursday the idea of a nondiscrimination law for the health care system in the country that clearly demands that medical providers as well as insurers to treat all patients without any bias, including transgender people.  Obamacare, or the Affordable Care Act, which was passed in 2010, comprises nondiscrimination provisions that deter insurers from denying insurance coverage based on sex or age or charge customers extra.  However, the law
Date: Sep 03

U.S. Oil Settles to $46.75 per Barrel, Up 1%
A loss was gain seen in crude futures after they rose more than 4 per cent on this Thursday as the equity market exhibited strong sales, the bad news out of China saw some respite and the potential for more monetary funds from Europe which added to risk taking in crude oil. But the positivity faded by the time afternoon trading had begun. By that time, the prices of oil had come down from the morning highs by the noon on Thursday, most likely owing to the prevailing weak market conditions for
Date: Sep 03

Chinese Rail Contractor Offers to Build High-Speed Railway in Sweden
A major rail contractor in China has, off the record, offered to build a planned high speed railway in Sweden for US$ 3 billion lesser and in five years fewer than what was initially estimated by the Sweden state transport administration. The contractor, China Railway Construction, made the confidential offer to the Sweden parliament’s Standing Committee for Transport. The document, however, was leaked to a national TV broadcaster of Sweden, SVT.  The offer by China claims to of
Date: Sep 02

Construction Spending in US Soars to Highest in 7 Years
Construction spending in the United States in the month of July jumped to a level that is the highest in over seven years, indicating that the business investment and the housing market can aid in underpinning economic development even amid turmoil beyond American boundaries.  The total construction spending rose by 0.7 per cent compared to the previous month to reach a seasonally adapted annual rate of US$ 1.083 trillion to mark the highest level since 2008 in May, according to the Comm
Date: Sep 02

Chinese E-commerce King Alibaba Seeking to Expand Latin America Presence
Alibaba, the e-commerce e giant in China is seeking ways to expand presence in Latin Amer4iac, as stated by Michael Lee, head of business development and international marketing at Alibaba. The expansion of the company is basically focused on Brazil and Argentina, wherein the company has been steadily growing in the last few years, the business head further added. The declaration was made by the business head recently in Buenos Aires at a conference organized by Argentina Chamber for Elect
Date: Sep 02

Global PMI Index Shows Further Contraction in Chinas Manufacturing Sector
According to latest data, the manufacturing industry in China has further contracted while the euro zone and the U.S. growth eased in August. Keeping the recent developments of the world economy in view, the International Monetary Fund has lowered its forecast for world growth this year. Last month witnessed turbulence in Chinese economy affecting the stocks and the commodity prices on major markets.  The investors are wondering if the Federal Reserve would increase the interest rate in Septemb
Date: Sep 02

NASAs Developing Megawatt Solar Power Arrays for a Use with Solar Electric Propulsion
NASA Glenn Research Center, GRC, presently offers several programs to progress in the future photovoltaic array development. NASA Space Technology Program selected ATK- Alliant Technical Systems in 2012 for development of a neat solar array structure and lightweight structure, under a Game Changing Technology competition.   The project proposes the design and manufacture of deployable solar arrays based on TRI 5 (technology readiness). The project is larger than the solar array blankets insta
Date: Sep 02

Upcoming Reports

Rheumatoid Arthritis Pharmacotherapeutics Market - Global Industry Size, Market Share, Trends, Analysis And Forecast, 2012 - 2018
Treatment options for rheumatoid arthritis (RA) are expanding as a result of increasing research activities and more explicit understanding of the pathophysiology of diseases. For the treatment of RA, novel selective inhibitors such as cyclooxygenase-2 (COX-2) are used along with the non-steroidal
Published By: Transparency
Price: $5795
Prescription Arthritis Treatments Market: Singapore and Indonesia, Market Size, Growth and Industry Analysis
METHODOLOGY  Our research consists of both secondary and primary research with later constituting the greater portion. We also have a large internal repository and access to a number of external proprietary databases to help address specific requirements of our clients. The research proc
Published By: Transparency
Price: $5795
Psoriatic Arthritis Pharmacotherapy Market - Global Industry Analysis, Size, Share And Forecast, 2012 - 2018
Psoriatic Arthritis is a type of rheumatoid arthritis which mainly affects fingers and toes followed by psoriasis. Moreover, a condition in which person has both psoriasis and arthritis is identified to have suffered from psoriatic arthritis. Major symptom for psoriatic arthritis is associated wit
Published By: Transparency
Price: $5595
Pipeline Review Of Rheumatoid Arthritis Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2019
Rheumatoid arthritis (RA) is a chronic inflammatory autoimmune disease. The cause of rheumatoid arthritis is not known. The joint inflammation of rheumatoid arthritis causes swelling, pain, stiffness and redness in the joints. It can lead to a significant loss of mobility due to pain and joint destr
Published By: Transparency
Price: $5795